Advertisement

Topics

Where Will CNS Drug Development Go In 2018?

05:07 EDT 17 Aug 2017 | SCRIP

The world's expanding, aging population means diseases of the central nervous system, like Alzheimer's and Parkinson's, are potential blockbuster areas...

      

Related Stories

 

Original Article: Where Will CNS Drug Development Go In 2018?

NEXT ARTICLE

More From BioPortfolio on "Where Will CNS Drug Development Go In 2018?"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...